Saturday, October 5, 2019

Why BRCA mutations are not tumour-agnostic biomarkers for PARP inhibitor therapy NJ Curtin et al, Nature Rev Clin Oncology, October 3, 2019

Main|Search|PHGKB

BRCA


Last Posted: Oct 04, 2019


No comments:

Post a Comment